Observational studyZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Factors influencing hemorrhagic transformation after mechanical thrombectomy in patients with acute ischemic stroke patients].
Observational study in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPatients with acute ischemic stroke remain at risk of hemorrhagic transformation after mechanical thrombectomy, which may lead to neurological deterioration and adversely affect clinical outcomes. Early identification of related risk factors is therefore important for optimizing perioperative management. This study aimed to investigate the clinical factors associated with hemorrhagic transformation (HT) after mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS), and to further evaluate the value of these factors in combination for predicting the risk of HT after MT, thereby providing a reference for early identification of high-risk patients, optimization of perioperative management, and development of individualized follow-up strategies.
methodsThis was a single-center, prospective, observational cohort study. A total of 268 patients with AIS who underwent MT and had complete clinical data at the Stroke Center of Beijing Hospital between May 2020 and December 2024 were consecutively enrolled. All patients met the diagnostic criteria for AIS and the indications for vascular recanalization therapy. Patients were excluded if they had a pre-stroke Modified Rankin Scale score ≥3, hemorrhagic disorders or a clear bleeding tendency, onset-to-treatment time ≥24 h, large-area cerebral infarction, severe cardiac, pulmonary, hepatic, or renal disease, end-stage malignant tumors, loss to follow-up, or unwillingness to participate in follow-up. HT was determined according to cranial computed tomography (CT) or magnetic resonance imaging (MRI) findings within 14 days after MT, and the patients were divided into an HT group and a non-HT group. Data were collected using standardized case report forms, including demographic characteristics, previous stroke risk factors, use of antiplatelet drugs, unhealthy lifestyle factors, onset-to-thrombectomy time, baseline National Institutes of Health Stroke Scale (NIHSS) score, preoperative blood pressure, emergency laboratory test results, stroke etiological classification, infarct location, intravenous thrombolysis, thrombectomy method, and vascular recanalization status. The
resultsA total of 268 AIS patients were included in this study, including 156 males and 112 females, with a mean age of (72.6±12.9) years. HT occurred in 92 patients after MT, with an incidence of 34.3%. Among them, 29 patients had hemorrhagic infarction type 1 (HI-1), 24 had hemorrhagic infarction type 2 (HI-2), 16 had parenchymal hematoma type 1 (PH-1), and 23 had parenchymal hematoma type 2 (PH-2). Symptomatic intracranial hemorrhage (sICH) occurred in 15 patients, with an incidence of 5.6%. Compared with the non-HT group, the HT group had a higher proportion of patients with a history of coronary heart disease, a lower proportion of patients with a history of stroke, higher baseline NIHSS scores, a higher proportion of patients with NIHSS score ≥12, a lower proportion of posterior circulation infarction, and a lower rate of favorable outcome at 3 months (all
conclusionsThe incidence of HT after MT is relatively high in patients with AIS. A baseline NIHSS score ≥12 and a history of coronary heart disease were identified as independent risk factors for HT, whereas a higher fibrinogen level was an independent protective factor. The predictive model developed in this study may facilitate early identification of HT risk; however, further optimization through the incorporation of additional imaging and perioperative variables, as well as validation in multicenter studies, is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.